Leading Companies Enhancing Their Presence in the Biopreservation Market

The biopreservation industry is poised for significant expansion as it plays an increasingly vital role in medical research and healthcare. With advances in technology and growing needs in regenerative medicine and clinical trials, this market is set to achieve remarkable growth in the coming years. Below, we explore its projected market size, influential companies, key segments, and recent developments shaping the future of biopreservation.

Projected Market Size and Growth Trajectory of the Biopreservation Market
The biopreservation market is anticipated to experience rapid expansion, reaching a value of $12.43 billion by 2030. This growth corresponds to a robust compound annual growth rate (CAGR) of 13.2%. Several factors contribute to this upward trend, including a rising demand for regenerative medicine samples, the broadening scope of precision medicine research, and increased investments in biorepository infrastructures. Additionally, there is heightened attention on ensuring sample quality and a surge in global clinical trial activities. Key evolving trends include greater implementation of advanced cryopreservation techniques, expanding requirements for long-term biospecimen storage, the use of specialized preservation media, growth in centralized biorepository centers, and intensified focus on maintaining sample integrity and traceability throughout the preservation process.

Download a free sample of the biopreservation market report:
https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies Driving the Biopreservation Market Forward
The biopreservation sector is shaped by a number of prominent players, including Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., and BioSpherix Ltd. These companies play crucial roles in advancing technologies and expanding infrastructure to meet the increasing market demands.

Noteworthy Collaboration Enhancing Biopreservation Capabilities
In June 2024, DefiniGEN Ltd., a UK biotechnology firm, teamed up with Atelerix Ltd. with the goal of transforming drug testing procedures. Their partnership focuses on improving efficiency and sustainability by enabling the transport of functional in vitro liver models without relying on cold chain logistics. Atelerix Ltd., also based in the UK, specializes in developing and commercializing innovative cell-based therapies and regenerative medicine solutions, making this collaboration a promising step toward more practical and cost-effective drug testing methods.

The biopreservation industry is poised for significant expansion as it plays an increasingly vital role in medical research and healthcare. With advances in technology and growing needs in regenerative medicine and clinical trials, this market is set to achieve remarkable growth in the coming years. Below, we explore its projected market size, influential companies, key segments, and recent developments shaping the future of biopreservation.

Projected Market Size and Growth Trajectory of the Biopreservation Market
The biopreservation market is anticipated to experience rapid expansion, reaching a value of $12.43 billion by 2030. This growth corresponds to a robust compound annual growth rate (CAGR) of 13.2%. Several factors contribute to this upward trend, including a rising demand for regenerative medicine samples, the broadening scope of precision medicine research, and increased investments in biorepository infrastructures. Additionally, there is heightened attention on ensuring sample quality and a surge in global clinical trial activities. Key evolving trends include greater implementation of advanced cryopreservation techniques, expanding requirements for long-term biospecimen storage, the use of specialized preservation media, growth in centralized biorepository centers, and intensified focus on maintaining sample integrity and traceability throughout the preservation process.

Download a free sample of the biopreservation market report:
https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Driving the Biopreservation Market Forward
The biopreservation sector is shaped by a number of prominent players, including Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., and BioSpherix Ltd. These companies play crucial roles in advancing technologies and expanding infrastructure to meet the increasing market demands.

Noteworthy Collaboration Enhancing Biopreservation Capabilities
In June 2024, DefiniGEN Ltd., a UK biotechnology firm, teamed up with Atelerix Ltd. with the goal of transforming drug testing procedures. Their partnership focuses on improving efficiency and sustainability by enabling the transport of functional in vitro liver models without relying on cold chain logistics. Atelerix Ltd., also based in the UK, specializes in developing and commercializing innovative cell-based therapies and regenerative medicine solutions, making this collaboration a promising step toward more practical and cost-effective drug testing methods.

Breakdown of Market Segments and Forecasts in the Global Biopreservation Industry
The biopreservation market is divided into several segments for detailed analysis, including:
1) By Type: Biopreservation Equipment and Biopreservation Media
2) By Biospecimen: Human Tissue Samples, Organs, Stem Cells, and Other Biospecimens
3) By Application: Therapeutic Applications, Research Applications, Clinical Trials, and Other Applications
4) By End User: Biobanks, Gene Banks, Hospitals, and Other End Users

Further subcategories include:
- Biopreservation Equipment such as Freezers, Liquid Nitrogen Tanks, Refrigerators, and Incubators
- Biopreservation Media including Cryoprotectants, Growth Media, and Supplementary Media

This segmentation provides a comprehensive overview of the market's structure, helping stakeholders understand where demand is concentrated and where opportunities for innovation and investment lie.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.